FDA Brief

Warning letters Food

FDA warning letter to

Imu-Tek Animal Health, Incorporated

High riskIssued Jun 5Posted Jun 23Human Foods Program

FDA warns Imu-Tek Animal Health over unapproved drug claims and manufacturing failures for Colostrom-5 products.

What happened

FDA inspected the Fort Collins, CO facility from October 6 through October 14, 2025, and reviewed www.imutek.com in April 2026. The inspection found current good manufacturing practice (CGMP) failures for dietary supplements, including pasteurization deviations, no component or finished-product specifications, and no written master manufacturing record. The website claimed Colostrom-5 Capsules and Powder "kill bacteria and viral invaders" and help correct bowel dysfunction, making them unapproved new drugs and misbranded drugs.

What FDA found

  1. Website claims that Colostrom-5 Capsules and Powder kill bacteria and viral invaders and help correct bowel dysfunction make them drugs intended to treat disease, but FDA has not approved them as new drugs.

    21 U.S.C. 321(g)(1)(B), 321(p), 331(d), 355(a)
  2. The products are misbranded because they are intended for diseases that laypeople cannot safely diagnose or treat without a licensed practitioner, so they lack adequate directions for use.

    21 U.S.C. 352(f)(1); 21 CFR 201.5
  3. Quality control did not reject or approve the colostrum when pasteurization temperatures and hold times deviated from the company's procedure, and the colostrum was still used.

    21 CFR 111.113(b)(1)
  4. The company had not established component specifications for identity, purity, strength, composition, or contamination limits, and had not established finished-product specifications.

    21 CFR 111.70(b), 111.70(e); 111.73; 111.75
  5. The company did not have a written master manufacturing record for Colostrom-5 Capsules or Powder to ensure batch-to-batch uniformity.

    21 CFR 111.205(a); 111.210
  6. Batch production records for Colostrom-5 were missing required information such as component identifiers and weights, test results, finished-product specification documentation, packaging and labeling records, and quality control approval or rejection.

    21 CFR 111.260

What FDA wants

FDA asks Imu-Tek to notify it in writing within 15 working days of receipt of the letter about specific steps taken to address the violations and prevent recurrence, with related documentation. If corrective actions cannot be completed within 15 working days, the company must state the reason for delay and when it will finish.

Who should pay attention

  • animal health brands selling colostrum or immune-claim supplements
  • contract manufacturers and labelers of dietary supplements
  • retailers and distributors of animal supplements

This is a summary. Read the original letter on fda.gov.

Imu-Tek Animal Health, Incorporated's FDA history

Recalls in the last 12 months

Apr 8 Class II Imu-Tek Animal Health, Incorporated
Food
Imu-Tek Colostrum-5 120 Capsules; 30% IgG, 2 capsules 2x/day, orally with 8 ounces of water, support a healthy immune system, 3 year shelf life, plastic bottle, inner liner seal and shrink band seal, 500 mg capsule, 7 3…
Product is potentially under-processed.
Apr 8 Class II Imu-Tek Animal Health, Incorporated
Food
Imu-Tek Colostrum-5 Powder; 30% IgG,1,000 mg 2x/day, orally with 8 ounces of water, support a healthy immune system, 3 year shelf life, plastic bottle, inner liner seal and shrink band exterior seal, 24 ounces (680 grams…
Product is potentially under-processed.
Feb 11 Class II Imu-Tek Animal Health, Incorporated
Food
Imu-Tek Immuno-5 Colostrum Powder 7 oz. Intended Use: Dietary Supplement for People. (Some customers use this for their pets).Packaging: Plastic jar with Sealed lid. Net Weight: 7 ounces. UPC:7 38654 00033 5 Firm n…
Undeclared milk allergen

Full company page

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk